Nothing Special   »   [go: up one dir, main page]

DE2436332A1 - SUBSTITUTED TETRAHYDROFURANS AND PROCESS FOR THEIR PRODUCTION - Google Patents

SUBSTITUTED TETRAHYDROFURANS AND PROCESS FOR THEIR PRODUCTION

Info

Publication number
DE2436332A1
DE2436332A1 DE19742436332 DE2436332A DE2436332A1 DE 2436332 A1 DE2436332 A1 DE 2436332A1 DE 19742436332 DE19742436332 DE 19742436332 DE 2436332 A DE2436332 A DE 2436332A DE 2436332 A1 DE2436332 A1 DE 2436332A1
Authority
DE
Germany
Prior art keywords
hydrogen
chemical factory
tetrahydrofuran
substituted tetrahydrofurans
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19742436332
Other languages
German (de)
Inventor
Fritz Dipl Chem Dr Rer Binnig
Dieter Dipl Chem Dr Rer N Hotz
Harald Dipl Chem Dr Phi Tobias
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott GmbH and Co KG
Original Assignee
Knoll GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll GmbH filed Critical Knoll GmbH
Priority to DE19742436332 priority Critical patent/DE2436332A1/en
Priority to NL7507149A priority patent/NL7507149A/en
Priority to BE157491A priority patent/BE830423A/en
Priority to GB2669275A priority patent/GB1458164A/en
Priority to FR7522891A priority patent/FR2279751A1/en
Priority to AT572575A priority patent/AT342582B/en
Priority to JP9101475A priority patent/JPS5136492A/en
Publication of DE2436332A1 publication Critical patent/DE2436332A1/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Description

CHEMISCHE FABRIKEN
Patent-u.Lizenz-Abteilung . Ludwigshafen/Rh. , 23.7.I974
CHEMICAL FACTORY
Patent & License Department. Ludwigshafen / Rh. , July 23, 1974

Substituierte Tetrahydrofurane und Verfahren zu deren HerstellungSubstituted tetrahydrofurans and processes for their preparation

Die Erfindung betrifft neue, substituierte Tetrahydrofurane, die zur Herstellung von"Oxaprostaglandxnen geeignet sind.The invention relates to new, substituted tetrahydrofurans which are suitable for the production of "oxaprostaglandxnen" are.

Prostaglandine sind relativ schwer zugängliche Verbindungen. Da sie ein recht breites Wirkungsspektrum besitzen, ist eine gezielte therapeutische Anwendung sehr schwierig. Es ist daher von Interesse, Prostaglandin-ähnliche Substanzen darzustellen, die sich besser anwenden lassen. Prostaglandinderivate, die anstelle des Cyclopentanrings einen Butyrolactonring besitzen, sind bereits bekannt, nicht jedoch solche, die sich von einem Tetrahydrofurangerüst ableiten. Prostaglandins are compounds that are relatively difficult to access. Since they have a fairly broad spectrum of activity, a targeted therapeutic application is very difficult. It is therefore of interest to use prostaglandin-like substances that can be used better. Prostaglandin derivatives, which instead of the cyclopentane ring a Have butyrolactone ring are already known, but not those which are derived from a tetrahydrofuran structure.

Es wurde nun ein Zwischenprodukt gefunden, aus dem sich leicht 11-Oxaprostaglandine herstellen lassen.An intermediate product has now been found from which 11-oxaprostaglandins can easily be prepared.

Gegenstand der Erfindung sind Verbindungen der allgemeinen Formel IThe invention relates to compounds of the general formula I

509887/1013509887/1013

ORIGINAL INSPECTEDORIGINAL INSPECTED

CHEMISCHE FABRIKENCHEMICAL FACTORY

4 3 6 3 34 3 6 3 3

worin A die Gruppewhere A is the group

C=OC = O

OHOH

oderor

OHOH

mit R in der Bedeutung eines Alkylrestes mit 1-4 Kohlenstoffatomen ist undwith R meaning an alkyl radical with 1-4 carbon atoms is and

B einen verzweigten oder unverzweigten Alkylrest mit 1-10 Kohlenstoffatomen bedeutet.B denotes a branched or unbranched alkyl radical having 1-10 carbon atoms.

Gegenstand der Erfindung ist weiter ein Verfahren zur Herstellung von Verbindungen der allgemeinen Formel I, welches darin besteht, dass man eine Verbindung der allgemeinen Formel IIThe invention also relates to a method of production of compounds of the general formula I, which consists in the fact that one is a compound of the general formula II

CH3-CO-OCH 3 -CO-O

CH3CO-CH 3 CO-

••■■\•• ■■ \

00C2Hr 00C 2 H r

CHOR-CH2ORCHORUS-CH 2 OR

worin R ein Acetyl- oder Benzoylrest darstellt, mit Chloroder Bromwasserstoff reagieren lässt, einengt, in dem Rückstand mit Triphenylzinnhydrid das Halogen gegen Wasserstoff austauscht, das so erhaltene 2ß-(l',2'-Diacyloxyäthyl)-3acarbäthoxymethyl-4a-acetoxy-tetrahydrofuran mit Säure behandelt, einer Glykolspaltung unterwirft und anschliessend nach Wittig umsetzt.wherein R represents an acetyl or benzoyl radical, with chlorine or Lets hydrogen bromide react, constricts, in the residue with triphenyltin hydride the halogen against hydrogen exchanges the 2ß- (l ', 2'-diacyloxyethyl) -3acarbäthoxymethyl-4a-acetoxy-tetrahydrofuran thus obtained treated with acid, subjected to glycol cleavage and then according to Wittig.

ORIGINAL INSPECTEDORIGINAL INSPECTED

509887/1013509887/1013

CHEMISCHE FABRIKENCHEMICAL FACTORY

Die erfindungsgemässe Reaktion verläuft über folgende Stufen: The reaction according to the invention takes place in the following stages:

CH3COOCH 3 COO

CH3COOCH 3 COO

COOC0HCOOC 0 H

Halogen-Wasserstoff Halogen-hydrogen

CHOR-CH2OR CH3CO-OCHORUS-CH 2 OR CH 3 CO-O

Hal·Hal

COOC2II CHOR-CH2ORCOOC 2 II CHORUS-CH 2 OR

(C6H5J3SnH(C 6 H 5 J 3 SnH

CH3CO-OCH 3 CO-O

COOC0HCOOC 0 H

CHOR-CH2ORCHORUS-CH 2 OR

JO. 4JO. 4th

HOH-CH2OHHOH-CH 2 OH

WittigWittig

A-BAWAY

Π 9 B B 7 Π η 1 ORIGINAL INSPECTEDΠ 9 B B 7 Π η 1 ORIGINAL INSPECTED

2 4 3 B 3 32 4 3 B 3 3

CHEMISCHE FABRIKENCHEMICAL FACTORY

Der Umsatz des Ausgangsmaterials mit Chlor- oder Bromwasserstoff erfolgt vorzugsweise so, dass man die Substanz in einem Lösungsmittel wie Methylenchlorid, Chloroform oder Äther löst und den Halogenwasserstoff bis zur Sättigung einleitet. Dieser Reaktionsschritt kann auch mit Bromwasserstoff in Eisessig bei Gegenwart von Acetanhydrid durchgeführt werden. Der Austausch des Halogenatoms gegen ein Wasserstoffatom erfolgt durch Umsetzung mit Triphenylzinnhydrid vorzugsweise bei Raumtemperatur.The conversion of the starting material with hydrogen chloride or hydrogen bromide is preferably carried out so that the substance in a solvent such as methylene chloride, chloroform or Ether dissolves and the hydrogen halide to saturation initiates. This reaction step can also be carried out with hydrogen bromide in glacial acetic acid in the presence of acetic anhydride will. The halogen atom is exchanged for a hydrogen atom by reaction with triphenyltin hydride preferably at room temperature.

Die Ausbeuten bei der Lactonisierung von 2ß-(l',2'-Diacyloxyäthyl)-3a-carbäthoxymethyl-4a-acetoxy-tetrahydrofuran zu 2ß-(1', 2'-Dihydroxyäthyl)-3a-carboxymethyl-4a-hydroxy-tetrahydrofuran-4-lacton mit den üblichen Säuren und Lösungsmitteln sind in der Regel nicht sehr gut. Führt man diesen Reaktionsschritt jedoch mit p-Toluolsulfonsäure in Methanol durch, so erhält man Ausbeuten von über 70 %. The yields in the lactonization of 2ß- (l ', 2'-diacyloxyethyl) -3a-carbäthoxymethyl-4a-acetoxy-tetrahydrofuran to 2ß- (1', 2'-dihydroxyethyl) -3a-carboxymethyl-4a-hydroxy-tetrahydrofuran 4-lactone with the usual acids and solvents are usually not very good. However, if this reaction step is carried out with p-toluenesulfonic acid in methanol, yields of over 70 % are obtained.

Die Glykolspaltung kann in bekannter Weise durchgeführt werden. Im vorliegenden Fall hat sich Natriumperjodat als besonders geeignet erwiesen. Auch der Umsatz mit dem Wittig-Reagenz erfolgt in üblicher Weise.The glycol cleavage can be carried out in a known manner will. In the present case, sodium periodate has proven to be particularly suitable. Also sales with the Wittig reagent takes place in the usual way.

Das vorliegende Verfahren besitzt den Vorteil, dass als Ausgangematerial eine Substanz verwendet wird, die leicht aus Glukose erhältlich ist, und dass ein sterisch einheit-The present method has the advantage that, as a starting material, a substance is used which is easily is obtainable from glucose, and that a sterically uniform

-S--S-

7/10137/1013

CHEMISCHE FABRIKENCHEMICAL FACTORY

liches, optisch aktives Produkt erhalten wird. Die nach dem erfindungsgemässen Verfahren hergestellten Verbindungen entsprechen in ihrer sterischen Anordnung den natürlichen Prostaglandinen. Bislang musste man bei der Herstellung von hochsubstituierten Tetrahydrofuranen von Furan- oder Tetrahydrofuran-Verbindungen ausgehen. Diese Synthesen gestalten sich jedoch ausserordentlich schwierig und aufwendig, da die Furan-Verbindungen sehr empfind lich gegen Säure und Alkali sind und Gemische von Stereoisomeren anfallen. Liches, optically active product is obtained. The compounds prepared by the process according to the invention correspond in their steric arrangement to the natural prostaglandins. So far you had to make it of highly substituted tetrahydrofurans start from furan or tetrahydrofuran compounds. These However, syntheses are extremely difficult and expensive because the furan compounds are very sensitive Lich are against acid and alkali and mixtures of stereoisomers are produced.

5 0 9 B % 1 i 1 Π 1 35 0 9 B % 1 i 1 Π 1 3

3 6 3 33 6 3 3

CHECHE

Herstellung des Ausgangsmaterials.Production of the starting material.

a) Zu einer Lösung von 27 g S-Desoxy-S-carbäthoxymethyl-1,2-5,6-di-O-isopropyliden-oc-D-allofuranose (l) in 250 ml Methanol fügt man 250 ml 0,8%±ge wässrige Schwefelsäure. Nach 16 Stunden Stehenlassen bei Raumtemperatur wird mit BaCO,, neutralisiert, zwecks besserer FiI-trierbarkeit des Niederschlags kurz zum Sieden erhitzt, abfiltriert und das Methanol im Vakuum entfernt. Die verbleibende wässrige Lösung füllt man auf 250 ml auf, entfernt die organischen Verunreinigungen durch Ausschütteln mit η-Hexan und engt ein. Ausbeute: 18,9 g bzw. 83 % S-Desoxy-S-carbäthoxymethyl-l,2-0-isopropyliden-5i 6-dihydroxy-oc-D-allofuranose. a) 250 ml of 0.8% are added to a solution of 27 g of S-deoxy-S-carbäthoxymethyl-1,2-5,6-di-O-isopropylidene-oc-D-allofuranose (l) in 250 ml of methanol ± ge aqueous sulfuric acid. After 16 hours of standing at room temperature, it is neutralized with BaCO 2, heated briefly to boiling for the purpose of better filterability of the precipitate, filtered off and the methanol is removed in vacuo. The remaining aqueous solution is made up to 250 ml, the organic impurities are removed by shaking with η-hexane and concentrated. Yield: 18.9 g or 83 % of S-deoxy-S-carbethoxymethyl-1,2-0-isopropylidene-5i 6-dihydroxy-oc-D-allofuranose.

b) 5 g S-Desoxy-S-carbäthoxymethyl-l^-O-isopropyliden-5,6-dihydroxy-a-D-allofuranose löst man in 10 ml Pyridin und fügt 4 ml Acetanhydrid hinzu. Nach dreistündigem Stehenlassen bei Raumtemperatur wird in 100 ml Chloroform oder Methylenchlorid aufgenommen, mit 5%±gev Salz säure, 5%±ger Natronlauge und anschliessend mit Wasser gewaschen und nach Trocknung mit Na3SO. eingeengt. Ausbeute: 5,4 g S-Desoxy-S-carbäthoxymethyl-l^-isopropyliden-5$6-diacetoxy-a-D-allofuranose. b) 5 g of S-deoxy-S-carbäthoxymethyl-l ^ -O-isopropylidene-5,6-dihydroxy-aD-allofuranose are dissolved in 10 ml of pyridine and 4 ml of acetic anhydride are added. After standing for three hours at room temperature, it is taken up in 100 ml of chloroform or methylene chloride, washed with 5% ± gev hydrochloric acid, 5% ± ger sodium hydroxide solution and then with water and, after drying, with Na 3 SO. constricted. Yield: 5.4 g of S-deoxy-S-carbethoxymethyl-l ^ -isopropylidene- 5 $ 6-diacetoxy-aD-allofuranose.

509887/1013509887/1013

CHEMISCHE PABRIKENCHEMICAL PLANTS

243633?243633?

c) 5 g S-Desoxy-G-carbäthoxymethyl-l, 2-0-isopropyliden-5, o-diacetoxy-oc-D-allofuranose werden in 40 ml Eisessig gelöst und mit 4 ml Acetanhydrid und 0,6 ml konzentrierter H„S0, versetzt. Nach zweitägigem Stehenlassen schüttet man das Gemisch auf 500 ml Eis/Wasser und extrahiert erschöpfend mit Chloroform, trocknet die vereinigten organischen Phasen und engt ein. Ausbeute: 4,8 g (86 %) S-Desoxy-S-carbäthoxymethyl-l,2-5,6-tetraacetyl-a-D-allofuranose, c) 5 g of S-deoxy-G-carbäthoxymethyl-1,2-0-isopropylidene-5, o-diacetoxy-oc-D-allofuranose are dissolved in 40 ml of glacial acetic acid and mixed with 4 ml of acetic anhydride and 0.6 ml of concentrated water S0, offset. After standing for two days, the mixture is poured onto 500 ml of ice / water and extracted exhaustively with chloroform, the combined organic phases are dried and concentrated. Yield: 4.8 g (86 %) of S-deoxy-S-carbethoxymethyl-l, 2-5,6-tetraacetyl-aD-allofuranose,

509887/1013509887/1013

CHEMISCHE FABRIKENCHEMICAL FACTORY

Beispiel 1example 1

A) 6 g S-Desoxy-S-carbäthoxymethyl-l,2-5,6-tetraacetyla-D-allofuranose werden in 30 ml trockenem Methylenchlorid gelöst. Durch die Lösung leitet man 30 Minuten bei Raumtemperatur einen trockenen HBr-Strom und dampft anschliessend im Wasserstrahl-Vakuum unter Zwischenschaltung eines P_0--Trockenrohres zunächst bei Raumtemperatur ein. Zur Entfernung der noch anhaftenden Bromwasserstoffsäure steigert man die Temperatur nach Entfernung des Lösungsmittels für 30 Minuten auf 60°C.A) 6 g of S-deoxy-S-carbethoxymethyl-1,25,6-tetraacetyla-D-allofuranose are dissolved in 30 ml of dry methylene chloride. The solution is passed for 30 minutes a dry HBr stream at room temperature and then evaporated in a water jet vacuum with interposition of a P_0 drying tube initially at room temperature. To remove the still adhering Hydrobromic acid is raised to the temperature for 30 minutes after removal of the solvent 60 ° C.

B) Den Eindampfrückstand löst man unter Feuchtigkeitsausschluss in 30 ml trockenem Methylenchlorid und fügt 20 ml einer ätherischen Triphenylzinnhydrid-Lösung hinzu, welche aus 11 g Trxphenylzinnchlorid und 0,55 g LiAlH. bereitet wurde. Nach 30 Minuten dampft man ein und chromatographiert den Rückstand an desaktiviertem Kieselgel, Wassergehalt 30 %. Durch Elution mit η-Hexan trennt man zunächst die Verunreinigung ab, nach deren Entfernung mit Chloroform/Methanol 10;1 eluiert wird. Die Ausbeute an 2ß-(l»,2'-diacetoxyäthyl)· 3a-carbäthoxymethyl-4a-acetoxy-tetrahydrofuran beträgt 4,9 g oder 94 %. B) The evaporation residue is dissolved in 30 ml of dry methylene chloride with exclusion of moisture and 20 ml of an ethereal triphenyltin hydride solution, which is made up of 11 g of trxphenyltin chloride and 0.55 g of LiAlH, is added. was prepared. After 30 minutes, it is evaporated and the residue is chromatographed on deactivated silica gel, water content 30 %. The impurity is first separated off by elution with η-hexane, after which it is eluted with chloroform / methanol 10; 1. The yield of 2ß- (1 », 2'-diacetoxyethyl ).3a-carbethoxymethyl-4a-acetoxy-tetrahydrofuran is 4.9 g or 94 %.

~ 9 5Q9887/ in 1 3 ~ 9 5Q9887 / in 1 3

2 A 3 R 3 32 A 3 R 3 3

CHEMISCHE FABRIKENCHEMICAL FACTORY

C) 3,5 g 2ß-(l»,2'-Diacetoxyäthyl)-3oc-carbäthoxymethyl-4oc-acetoxy-tetrahydrofuran werden in 5 ml Methanol, welche 0,25 g p-Toluolsulfonsäure enthalten, gelöst und 16 Stunden unter Rückfluss am Sieden gehalten. Anschliessend wird eingeengt und an desaktiviertem Kieselgel, welches 30 % Wasser enthält, mit Chloroform/Methanol 10:1 chromatographiert. Die Ausbeute an 2ß~(l',2'-Dihydroxyäthyl)-3a-carboxymethyl-4a-hydroxy-tetrahydrofuran-4-1acton beträgt 1,3 g oder 72 %. C) 3.5 g 2ß- (l ', 2'-Diacetoxyäthyl) -3oc-carbäthoxymethyl-4oC-acetoxy-tetrahydrofuran contained p-toluenesulfonic acid in 5 m l of methanol, which 0.25 g, and treated for 16 hours under reflux kept simmering. It is then concentrated and chromatographed on deactivated silica gel which contains 30 % water with chloroform / methanol 10: 1. The yield of 2β ~ (l ', 2'-dihydroxyethyl) -3a-carboxymethyl-4a-hydroxy-tetrahydrofuran-4-lactone is 1.3 g or 72 %.

D) 5,4 g 2ß-(l',2'-Dihydroxyäthyl)-3a-carboxymethyl-4ahydroxy-tetrahydrofuran-4-1acton werden in 25 ml Wasser gelöst und portionsweise mit 5 g NaJO . versetzt, wobei man durch Zufügen von 5#iger wässriger NaOII ρ 7 einhält. Danach wird mit Chloroform/lsopropanol erschöpfend extrahiert, die vereinigten organischen Phasen mit Na0SO- getrocknet und eingeengt. Die Ausbeute an 2ß-Formyl-3a-carboxymethyl-4a-hydroxy-tetrahydrofuran-4-lacton beträgt 4,3 g oder 96 %. D) 5.4 g of 2β- (l ', 2'-dihydroxyethyl) -3a-carboxymethyl-4ahydroxy-tetrahydrofuran-4-lactone are dissolved in 25 ml of water and mixed in portions with 5 g of NaJO. added, while maintaining ρ 7 by adding 5 # aqueous NaOII. Thereafter, isopropanol exhaustively extracted with chloroform /, the combined organic phases with Na 0 SO- dried and concentrated. The yield of 2β-formyl-3a-carboxymethyl-4a-hydroxy-tetrahydrofuran-4-lactone is 4.3 g or 96 %.

E) 12,6 g 2ß-Formyl-3a-carboxymethyl-4a-hydroxy-tetrahydrofuran-4-1acton werden in 500 ml Tetrahydrofuran gelöst und mit 60 g Hexanoylmethylen-triphenylphosphoran eine Stunde unter Rückfluss am Sieden gehalten. Man dampft ein und löst den Rückstand in Essigsäureäthylester, wobei die Hauptmenge an Triphenylphosphin-E) 12.6 g of 2β-formyl-3a-carboxymethyl-4a-hydroxy-tetrahydrofuran-4-1actone are dissolved in 500 ml of tetrahydrofuran and 60 g of hexanoylmethylene triphenylphosphorane kept at the boil for one hour under reflux. It is evaporated and the residue is dissolved in ethyl acetate, where the main amount of triphenylphosphine

- 10 -- 10 -

509887/1013509887/1013

243R332243R332

CHEMISCHE FABRIKENCHEMICAL FACTORY

oxid auskristallisisrt. Man saugt von der Verunreinigung ab, engt die Mutterlauge ein und löst den Eindampfrückstand in wenig Äther. Beim Versetzen der ätherischen Lösung mit η-Hexan fällt das 2ß-(Oct-l-en-3-onyl)~3oc-carboxymethyl-4a-hydroxy-tetrahydrofuran-4-lacton kristallinoxide crystallized out. One sucks off the contamination from, concentrates the mother liquor and dissolves the evaporation residue in a little ether. When moving the essential solution 2ß- (Oct-1-en-3-onyl) ~ 3oc-carboxymethyl-4a-hydroxy-tetrahydrofuran-4-lactone precipitates with η-hexane crystalline

Fp 66°C, Ausbeute 13,1 g oder 64$.Mp 66 ° C, yield 13.1 g or $ 64.

Beispiel 2Example 2

5 g S-Desoxy-S-carbäthoxymethyl-l^-Sjo-tetraacetyl-a-D-allofuranose werden in einer Mischung von 20 ml Eisessig und 4 ml Acetanhydrid gelöst. Nach Zufügen von 15 ml HBr/Eisessig 40 % Iä3st man 90 Minuten bei Raumtemperatur stehen und engt anschliessend im Hochvakuum ein, wobei die Temperatur allmählich auf 70°C gesteigert wird. Der Eindampfrückstand wird wie in Beispiel IB-E beschrieben weiterbehandelt. Die Ausbeute entspricht der des Beispiels 1.5 g of S-deoxy-S-carbäthoxymethyl-l ^ -Sjo-tetraacetyl-aD-allofuranose are dissolved in a mixture of 20 ml of glacial acetic acid and 4 ml of acetic anhydride. After adding 15 ml of HBr / glacial acetic acid 40 %, the mixture is left to stand at room temperature for 90 minutes and then concentrated in a high vacuum, the temperature gradually increasing to 70.degree. The evaporation residue is treated further as described in Example IB-E. The yield corresponds to that of Example 1.

Beispiel 3Example 3

In eine Lösung von 6 g S-Desoxy-S-carbäthoxymethyl-l,2-5,6-tetraacetyl-a-D-allofuranose in 30 ml Methylenchlorid lei-In a solution of 6 g of S-deoxy-S-carbäthoxymethyl-1,25,6-tetraacetyl-a-D-allofuranose in 30 ml of methylene chloride

- Il -- Il -

509837/1013509837/1013

2 k 3 R 3 3 ? 2 k 3 R 3 3 ?

CHEMISCHE FABRIKENCHEMICAL FACTORY

tet man bei O C etwa zwei Stunden einen Strom von trockenem HCl-Gas ein und lässt anschliessend etwa eine Woche bei Raumtemperatur stehen. Anschliessend behandelt man das Gemisch wie in Beispiel IB-E beschrieben, die Ausbeute an dem Endprodukt ist etwas geringer als die des Beispiels 1.a stream of dry water is used at OC for about two hours HCl gas and then leave to stand for about a week at room temperature. Then you treat the mixture as described in Example IB-E, the yield on the end product is slightly lower than that of Example 1.

Dr.WK/bu/2Dr.WK / bu / 2

- 12 -- 12 -

9 8 *Π Π fH 39 8 * Π Π fH 3

Claims (2)

CHEMISCHE FABRIKENCHEMICAL FACTORY Patent- und Lizenz-Abteilung P 159Patent and License Department P 159 Ludwigshafen am Rhein, den 23. Juli 1974Ludwigshafen am Rhein, July 23, 1974 Patentansprüche 1.) Substituierte Tetrahydrofurane der allgemeinen Formel IClaims 1.) Substituted tetrahydrofurans of the general formula I \a -\ a - A-BAWAY worin A die Gruppewhere A is the group C=OC = O IIII oderor OHOH OHOH mit R in der Bedeutung eines Alkylrestes mit 1-4 Kohlenstoffatomen ist undwith R meaning an alkyl radical with 1-4 carbon atoms is and B einen verzweigten oder unverzweigten Alkylrest mit 1-10 Kohlenstoffatomen bedeutet.B denotes a branched or unbranched alkyl radical having 1-10 carbon atoms. 2.) Verfahren zur Herstellung von substituierten Tetrahydrofuranen gemäss Anspruch 1, dadurch gekennzeichnet, dass man eine Verbindung der allgemeinen Formel II2.) Process for the production of substituted tetrahydrofurans according to claim 1, characterized in that a compound of the general formula II -13 --13 - CHEMISCHE FABRIKENCHEMICAL FACTORY CH3COCH 3 CO sCOOC0H-CHOR-CH2OR s COOC 0 H-CHORUS-CH 2 OR IIII worin R ein Acetyl- oder Benzoylrest darstellt, mit Chlor- oder Bromwasserstoff reagieren lässt, einengt, in dem Rückstand mit Triphenylzinnhydrid das Halogen gegen Wasserstoff austauscht, das so erhaltene 2ß-(1»,2'-Diacyloxyäthyl)-3a-carbäthoxymethyl-4a-acetoxytetrahydrofuran mit Säure behandelt, einer Glykolspaltung unterwirft und anschliessend nach Wittig umsetzt .where R represents an acetyl or benzoyl radical, reacts with hydrogen chloride or hydrogen bromide, constricts, in the residue with triphenyltin hydride the halogen exchanges for hydrogen, the 2ß- (1 », 2'-diacyloxyethyl) -3a-carbäthoxymethyl-4a-acetoxytetrahydrofuran thus obtained treated with acid, subjected to glycol cleavage and then reacted according to Wittig . 509887/1013509887/1013
DE19742436332 1974-07-27 1974-07-27 SUBSTITUTED TETRAHYDROFURANS AND PROCESS FOR THEIR PRODUCTION Pending DE2436332A1 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
DE19742436332 DE2436332A1 (en) 1974-07-27 1974-07-27 SUBSTITUTED TETRAHYDROFURANS AND PROCESS FOR THEIR PRODUCTION
NL7507149A NL7507149A (en) 1974-07-27 1975-06-16 SUBSTITUTED TETRAHYDROFURANS AND METHOD OF PREPARATION.
BE157491A BE830423A (en) 1974-07-27 1975-06-19 SUBSTITUTE TETRAHYDROFORANES AND PREPARATION PROCESS
GB2669275A GB1458164A (en) 1974-07-27 1975-06-24 Substituted tetrahydrofurans
FR7522891A FR2279751A1 (en) 1974-07-27 1975-07-22 SUBSTITUTE TETRAHYDROFURANS AND PROCESS FOR THEIR MANUFACTURE
AT572575A AT342582B (en) 1974-07-27 1975-07-24 METHOD FOR PRODUCING NEW SUBSTITUTED TETRAHYDROFURANS
JP9101475A JPS5136492A (en) 1974-07-27 1975-07-25 CHIKANTETORAHIDOROFURANNO SEIHO

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19742436332 DE2436332A1 (en) 1974-07-27 1974-07-27 SUBSTITUTED TETRAHYDROFURANS AND PROCESS FOR THEIR PRODUCTION

Publications (1)

Publication Number Publication Date
DE2436332A1 true DE2436332A1 (en) 1976-02-12

Family

ID=5921758

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19742436332 Pending DE2436332A1 (en) 1974-07-27 1974-07-27 SUBSTITUTED TETRAHYDROFURANS AND PROCESS FOR THEIR PRODUCTION

Country Status (7)

Country Link
JP (1) JPS5136492A (en)
AT (1) AT342582B (en)
BE (1) BE830423A (en)
DE (1) DE2436332A1 (en)
FR (1) FR2279751A1 (en)
GB (1) GB1458164A (en)
NL (1) NL7507149A (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1532551A (en) * 1975-01-16 1978-11-15 Chembro Holdings Pty Ltd Furo(3,4-6)furone derivatives and their preparation
US6025044A (en) 1993-08-18 2000-02-15 W. L. Gore & Associates, Inc. Thin-wall polytetrafluoroethylene tube
US5814660A (en) * 1995-12-22 1998-09-29 Alcon Laboratories, Inc. 9-oxa prostaglandin analogs as ocular hypotensives
EP0869794B1 (en) * 1995-12-22 2004-08-11 Alcon Laboratories, Inc. Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
US5866602A (en) * 1995-12-22 1999-02-02 Alcon Laboratories, Inc. Keto-substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives

Also Published As

Publication number Publication date
NL7507149A (en) 1976-01-29
GB1458164A (en) 1976-12-08
BE830423A (en) 1975-12-19
AT342582B (en) 1978-04-10
FR2279751A1 (en) 1976-02-20
ATA572575A (en) 1977-08-15
JPS5136492A (en) 1976-03-27

Similar Documents

Publication Publication Date Title
DE2827627A1 (en) NEW COMPOUNDS WITH A CYCLOPROPAN RING, PROCESS FOR THEIR PRODUCTION AND THEIR USE IN THE PRODUCTION OF CYCLOPROPANE DERIVATIVES WITH A DIHALOVINYL CHAIN
DE2436332A1 (en) SUBSTITUTED TETRAHYDROFURANS AND PROCESS FOR THEIR PRODUCTION
DE2609015A1 (en) PROCESS FOR THE PREPARATION OF BENZ (F) -2,5-OXAZOCINES
DE2850885A1 (en) BICYCLIC PROSTAGLANDINE, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AND VETERINE MEDICAL CONTAINERS THEREOF
DE2211397A1 (en) New esters and methods of making them
DE1288602B (en) Process for making steroid compounds
CH645623A5 (en) 2-Methyl-3-acetoxy-4,5-bis(halomethyl)pyridines, process for their preparation and process for the preparation of pyridoxin
DE2833967A1 (en) METHOD FOR PRODUCING APOVINCAMINE
DE1807585C3 (en) 14,15beta-epoxy cardenolides, processes for their preparation and compositions containing them
AT274248B (en) Process for the preparation of new derivatives of bufadienolide glycosides
DE2246867A1 (en) TETRAHYDROXY-BICYCLO- SQUARE BRACKET ON 3.3.0 SQUARE BRACKET TO -OCTANE
DE2449327C2 (en) 7α-hydroxy-estradiols, processes for their preparation and medicaments containing them
DE958839C (en) Process for the preparation of 2,4b-dimethyldodecahydrophenanthrene compounds
AT326638B (en) PROCESS FOR THE PREPARATION OF N (BETA DIETYLAMINO ETHYL) -4-AMINO-5-CHLORO-2-METHOXYBENZAMIDE
DE2220796C2 (en) Process for the preparation of 3-glucos-2-yl-3-desmethylthiocolchicine and of 2-glucos-2-yl-2-desmethylthiocolchicine
DE2162569C3 (en) Process for the preparation of 9beta, llbeta-epoxy derivatives of steroids
AT349030B (en) PROCESS FOR THE PRODUCTION OF NEW 8-HYDROXY-3-HALOGENMETHYL-4-ACETOXY-10-METHYLENE-2,9-DIOXATRICYCLO (4,3,1,03,7) DECANES OR OF THE APPROPRIATE 8-OXO DERIVATIVES
AT243447B (en) Process for the preparation of 16-pregnenes oxygenated in position 11
SU899573A1 (en) Process for preparing racemic 3-methyl ester of 1,8,d-bis-homo-estradiol
AT226383B (en) Process for the production of new steroid compounds
DE1593807C (en) alpha ascine methyl or ethy (ester, as well as a process for their production
DE1793344B2 (en) 2-HALOGEN-18-METHYL-1-ANDROSTENE, METHOD FOR MANUFACTURING THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE
DE1643012B2 (en) PROCESS FOR THE MANUFACTURING OF BUTENOLIDES
DE2022695A1 (en) 21-phosphate pregnanes
DE1933090A1 (en) Process for the preparation of cardiac pyranosides

Legal Events

Date Code Title Description
OHN Withdrawal